Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR.
Abstract
A cohort study of patients with moderate-severe psoriasis registered to the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) determined that there was no association between developing a first basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) following treatment with biologic therapy when compared to non-biologic systemic therapies.
| Authors | Mason, Kayleigh J; Burden, A David; Barker, Jonathan Nwn; Lunt, Mark; Ali, Hassan; Kleyn, C Elise; McElhone, Kathleen; Soliman, Moetaza M; Green, Adele C; Griffiths, Christopher Em; Reynolds, Nick J; Ormerod, Anthony D; , |
|---|---|
| Journal | Journal of the European Academy of Dermatology and Venereology : JEADV |
| Pages | e498-e501 |
| Volume | 35 |
| Date | 1/01/2021 |
| Grant ID | |
| Funding Body | |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1111/jdv.17230 |